Understanding Risk Factors for Alzheimer's Disease: Interplay of Neuroinflammation, Connexin-based Communication and Oxidative Stress

Archives of Medical Research

Volumn 43, Issue 8, 2012, Pages 632-644

  Quintanilla, Rodrigo A ^a   Orellana, Juan A ^a   von Bernhardi, Rommy ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

A ; Alzheimer's disease; Gap junctions; Glia; Hemichannels; Inflammation; Neurodegeneration; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; CONNEXIN 30; CONNEXIN 32; CONNEXIN 36; CONNEXIN 43; GAP JUNCTION PROTEIN; MITOCHONDRIAL DNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PURINERGIC P2X RECEPTOR; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

AGE; ALZHEIMER DISEASE; AMYLOID PLAQUE; BRAIN CELL; CELL INTERACTION; DNA DAMAGE; GAP JUNCTION; HUMAN; MACROGLIA; MICROGLIA; MOLECULAR PATHOLOGY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; CONNEXINS; GAP JUNCTIONS; HUMANS; INFLAMMATION; MITOCHONDRIA; NEUROGLIA; NEURONS; OXIDATIVE STRESS; RISK FACTORS; TAU PROTEINS;

EID: 84871658247     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.10.016     Document Type: Review

References (158)

1. Small S.A., Duff K. Linking Aβ and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 2008, 60:534-542.
2. Binder L.I., Guillozet-Bongaarts A.L., Garcia-Sierra F., et al. Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta 2005, 1739:216-223.
3. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 2001, 3:75-80.
4. Reddy P.H., Beal M.F. Are mitochondria critical in the pathogenesis of Alzheimer's disease?. Brain Res Brain Res Rev 2005, 49:618-632.
5. von Bernhardi R., Eugenín J. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid Redox Signal 2012, 16:974-1031.
6. von Bernhardi R. Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox Res 2007, 12:215-232.
7. Nguyen M.D., Julien J.P., Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat Rev Neurosci 2002, 3:216-227.
8. Saud K., Herrera-Molina R., von Bernhardi R. Pro- and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells. Neurotox Res 2005, 8:277-287.
9. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002, 35:419-432.
10. Sáez J.C., Berthoud V.M., Branes M.C., et al. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003, 83:1359-1400.
11. Schalper K.A., Palacios-Prado N., Orellana J.A., et al. Currently used methods for identification and characterization of hemichannels. Cell Commun Adhes 2008, 15:207-218.
12. Sáez J.C., Schalper K.A., Retamal M.A., et al. Cell membrane permeabilization via connexin hemichannels in living and dying cells. Exp Cell Res 2010, 316:2377-2389.
13. Shestopalov V.I., Panchin Y. Pannexins and gap junction protein diversity. Cell Mol Life Sci 2008, 65:376-394.
14. Ishikawa M., Iwamoto T., Nakamura T., et al. Pannexin 3 functions as an ER Ca2+ channel, hemichannel, and gap junction to promote osteoblast differentiation. J Cell Biol 2011, 193:1257-1274.
15. Bruzzone R., Hormuzdi S.G., Barbe M.T., et al. Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci USA 2003, 100:13644-13649.
16. MacVicar B.A., Thompson R.J. Non-junction functions of pannexin-1 channels. Trends Neurosci 2010, 33:93-102.
17. Orellana J.A., Sáez P.J., Shoji K.F., et al. Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid Redox Signal 2009, 11:369-399.
18. Schalper K.A., Orellana J.A., Berthoud V.M., et al. Dysfunctions of the diffusional membrane pathways mediated by hemichannels in inherited and acquired human diseases. Curr Vasc pharmacol 2009, 7:486-505.
19. Lynn B.D., Marotta C.A., Nagy J.I. Propagation of intercellular calcium waves in PC12 cells overexpressing a carboxy-terminal fragment of amyloid precursor protein. Neurosci Lett 1995, 199:21-24.
20. Nagy J.L., Li W., Hertzberg E.L., et al. Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease. Brain Res 1996, 717:173-178.
21. Haughey N.J., Mattson M.P. Alzheimer's amyloid beta-peptide enhances ATP/gap junction-mediated calcium-wave propagation in astrocytes. Neuromol Med 2003, 3:173-180.
22. Scemes E., Giaume C. Astrocyte calcium waves: what they are and what they do. Glia 2006, 54:716-725.
23. Stout C.E., Costantin J.L., Naus C.C., et al. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 2002, 277:10482-10488.
24. Kang J., Kang N., Lovatt D., et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci 2008, 28:4702-4711.
25. Suadicani S.O., Brosnan C.F., Scemes E. P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2R signaling. J Neurosci 2006, 26:1378-1385.
26. 2+ acts as a mediator of communication from neurons to glia. Sci Signal 2012, 5:ra8.
27. Cruz N.F., Ball K.K., Dienel G.A. Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice. ASN Neuro 2010, 2:e00041.
28. Retamal M.A., Froger N., Palacios-Prado N., et al. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci 2007, 27:13781-13792.
29. Bélanger M., Allaman I., Magistretti P.J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 2011, 14:724-738.
30. Allaman I., Gavillet M., Bélanger M., et al. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 2010, 30:3326-3338.
31. Blanc E.M., Bruce-Keller A.J., Mattson M.P. Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of Ca2+ homeostasis and cell death. J Neurochem 1998, 70:958-970.
32. Meme W., Calvo C.N., Froger N., et al. Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. FASEB J 2006, 20:494-496.
33. Andrade-Rozental A.F., Rozental R., Hopperstad M.G., et al. Gap junctions: the kiss of death and the kiss of life. Brain Res Brain Res Rev 2000, 32:308-315.
34. Farahani R., Pina-Benabou M.H., Kyrozis A., et al. Alterations in metabolism and gap junction expression may determine the role of astrocytes as good samaritans or executioners. Glia 2005, 50:351-361.
35. Eugenin E.A., Berman J.W. Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J Neurosci 2007, 27:12844-12850.
36. Peters O., Schipke C.G., Philipps A., et al. Astrocyte function is modified by Alzheimer's disease-like pathology in aged mice. J Alzheimers Dis 2009, 18:177-189.
37. Orellana J.A., Shoji K.F., Abudara V., et al. Amyloid β-induced death in neurons involves glial and neuronal hemichannels. J Neurosci 2011, 31:4962-4977.
38. Ye Z.C., Wyeth M.S., Baltan-Tekkok S., et al. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci 2003, 23:3588-3596.
39. Orellana J.A., Froger N., Ezan P., et al. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem 2011, 118:826-840.
40. Takeuchi H., Jin S., Wang J., et al. Tumor necrosis factor-α induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 2006, 281:21362-21368.
41. Thompson R.J., Jackson M.F., Olah M.E., et al. Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science 2008, 322:1555-1559.
42. Iglesias R., Locovei S., Roque A., et al. P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am J Physiol Cell Physiol 2008, 295:C752-C760.
43. Locovei S., Wang J., Dahl G. Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett 2006, 580:239-244.
44. Takeuchi H., Mizoguchi H., Doi Y., et al. Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. PLoS One 2011, 6:e21108.
45. Koulakoff A., Mei X., Orellana J.A., et al. Glial connexin expression and function in the context of Alzheimer's disease. Biochim Biophys Acta 2012, 1818:2048-2057.
46. Nagy J.I., Li W., Hertzberg E.L., et al. Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease. Brain Res 1996, 717:173-178.
47. Kuchibhotla K.V., Goldman S.T., Lattarulo C.R., et al. Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 2008, 59:214-225.
48. Mei X., Ezan P., Giaume C., et al. Astroglial connexin immunoreactivity is specifically altered at beta-amyloid plaques in beta-amyloid precursor protein/presenilin1 mice. Neuroscience 2010, 45:37-46.
49. Perea G., Navarrete M., Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009, 32:421-431.
50. Silverman W.R., de Rivero Vaccari J.P., Locovei S., et al. The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem 2009, 284:18143-18151.
51. Smith M.A., Rottkamp C.A., Nunomura A., et al. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 2000, 1502:139-144.
52. Zhu X., Raina A.K., Lee H.-G., et al. Oxidative stress signalling in Alzheimer's disease. Brain Res 2004, 1000:32-39.
53. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994, 36:747-751.
54. Gabbita S.P., Lovell M.A., Markesbery W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem 1998, 71:2034-2040.
55. Butterfield D.A., Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 2001, 122:945-962.
56. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002, 32:797-803.
57. Nunomura A., Perry G., Pappolla M.A., et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999, 19:1959-1964.
58. Lovell M.A., Ehmann W.E., Butler S.M., et al. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995, 45:1594-1601.
59. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 1998, 19:33-36.
60. Pratico D., Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 2004, 6:171-175.
61. Williams T.I., Lynn B.C., Markesbery W.R., et al. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging 2006, 27:1094-1099.
62. Marcus D.L., Thomas C., Rodriguez C., et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 1998, 150:40-44.
63. Padurariu M., Ciobica A., Hritcu L., et al. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2010, 469:6-10.
64. Furuta A., Price D.L., Pardo C.A., et al. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am J Pathol 1995, 146:357-367.
65. Omar R.A., Chyan Y.J., Andorn A.C., et al. Increased expression but reduced activity of antioxidant enzymes in Alzheimer's Disease. J Alzheimers Dis 1999, 1:139-145.
66. Ansari M.A., Scheff S.W. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 2010, 69:155-167.
67. Crouch P.J., Harding S.M., White A.R., et al. Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease. IJBCB 2008, 40:181-198.
68. Murakami K., Murata N., Noda Y., et al. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 2011, 286:44557-44568.
69. Okado-Matsumoto A., Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu, Zn-SOD in mitochondria. J Biol Chem 2001, 276:38388-38393.
70. Shelat P.B., Chalimoniuk M., Wang J.-H., et al. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 2008, 106:45-55.
71. McManus M.J., Murphy M.P., Franklin J.L. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J Neurosci 2011, 31:15703-15715.
72. Pagani L., Eckert A. Amyloid-β interaction with mitochondria. Int J Alzheimers Dis 2011, 9:255-260.
73. Wang X., Su B., Fujioka H., et al. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am J Pathol 2008, 173:470-482.
74. Calkins M.J., Manczak M., Mao P., et al. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 2011, 20:4515-4529.
75. Wang X., Su B.O., Lee H.G., et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 2009, 29:9090-9103.
76. Nisoli E., Clementi E., Paolucci C., et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299:896-899.
77. Clementi E., Brown G.C., Feelisch M., et al. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 1998, 95:7631-7636.
78. Dahm C.C., Moore K., Murphy M.P. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J Biol Chem 2006, 281:10056-10065.
79. Cleeter M.W., Cooper J.M., Darley-Usmar V.M., et al. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994, 345:50-54.
80. Cho D.H., Nakamura T., Fang J., et al. S-nitrosylation of Drp1mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
81. Gillardon F., Rist W., Kussmaul L., et al. Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition. Proteomics 2007, 7:605-616.
82. Reddy P.H., McWeeney S., Park B.S., et al. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 2004, 13:1225-1240.
83. Chen G., Chen K.S., Knox J., et al. A learning deficit related to age and beta- amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000, 408:975-979.
84. Keil U., Bonert A., Marques C.A., et al. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 2004, 279:50310-50320.
85. Caspersen C., Wang N., Yao J., et al. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 2005, 19:2040-2043.
86. Eckert A., Hauptmann S., Scherping I., et al. Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodeg Dis 2008, 5:157-159.
87. Ballatore C., Lee V.M., Trojanowski J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 2007, 8:663-672.
88. Farías G., Cornejo A., Jiménez J., et al. Mechanisms of tau self-aggregation and neurotoxicity. Curr Alzheimer Res 2011, 8:608-614.
89. Mi K., Johnson G.V. The role of tau phosphorylation in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2006, 3:449-463.
90. Gotz J., Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 2008, 9:532-544.
91. Dolan P.J., Johnson G.V. The role of tau kinases in Alzheimer's disease. Curr Opin Drug Discov Devel 2010, 13:595-603.
92. Yoshiike Y., Yamashita S., Mizoroki T., et al. Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes. Aging Cell 2012, 11:51-62.
93. Zambrano C.A., Egaña J.T., Núñez M.T., et al. Oxidative stress promotes tau dephosphorylation in neuronal cells: the roles of cdk5 and PP1. Free Radic Biol Med 2004, 36:1393-1402.
94. Dias-Santagata D., Fulga T.A., Duttaroy A., et al. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest 2007, 117:236-245.
95. Kulic L., Wollmer M.A., Rhein V., et al. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Neurobiol Aging 2009, 32:1827-1838.
96. Stamer K., Vogel R., Thies E., et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 2002, 156:1051-1063.
97. Melov S., Adlard P.A., Morten K., et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2007, 2:e536.
98. Ittner L.M., Ke Y.D., Delerue F., et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397.
99. Reddy P.H. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res 2011, 1415:136-148.
100. Gotz J., Chen F., Barmettler R., et al. Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 2001, 276:529-534.
101. David D.C., Hauptmann S., Scherping I., et al. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem 2005, 280:23802-23814.
102. Cente M., Filipcik P., Pevalova M., et al. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. Eur J Neurosci 2006, 24:1085-1090.
103. Quintanilla R.A., Mattews-Roberson T.A., Dolan P.J., et al. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. J Biol Chem 2009, 284:18754-18766.
104. Quintanilla R.A., Dolan P.J., Din Y., et al. Truncated tau and Aβ cooperatively impair mitochondria in primary neurons. Neurobiol Aging 2012, 619:e25-e35.
105. Bubber P., Haroutunian V., Fisch G., et al. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 2005, 57:695-703.
106. Hauptmann S., Sherping I., Drose S., et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 2008, 30:1574-1586.
107. Rhein V., Song X., Wiesner A., et al. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci USA 2009, 106:20057-20062.
108. Yao J., Irwin R.W., Zhao L., et al. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2009, 34:14670-14675.
109. Trushina E., Nemutlu E., Chang S., et al. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. Plos One 2012, 7:e32737.
110. Wyss-Coray T., Rogers J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harbor Perspect Med 2012, 2:a006346.
111. Harry G.J., Lefebvre d'Hellencourt C., Bruccoleri A., et al. Age-dependent cytokine responses: trimethyltin hippocampal injury in wild-type, APOE knockout, and APOE4 mice. Brain Behav Immun 2000, 14:288-304.
112. Ramírez G., Rey S., von Bernhardi R. Proinflammatory stimuli induce microglial cell- mediated APP- and Ab- neurotoxicity in hippocampal cultures. J Alzheimer Dis 2008, 15:45-59.
113. von Bernhardi R., Tichauer J.E., Eugenin J. Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem 2010, 112:1099-1114.
114. Kierdorf K., Wang Y., Neumann H. Immune-mediated CNS damage. Results Probl Cell Differ 2010, 51:173-196.
115. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 2005, 26:349-354.
116. Rosales-Corral S., Reiter R.J., Tan D.X., et al. Functional aspects of redox control during neuroinflammation. Antioxid Redox Signal 2010, 13:193-247.
117. Reynolds A., Laurie C., Mosley R.L., et al. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 2007, 82:297-325.
118. Satoh T., Lipton S.A. Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci 2007, 30:37-45.
119. Tuppo E.E., Arias H.R. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 2005, 37:289-305.
120. Conde J.R., Streit W.J. Microglia in the aging brain. J Neuropathol Exp Neurol 2006, 65:199-203.
121. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69.
122. Makar T.K., Nedergaard M., Preuss A., et al. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J Neurochem 1994, 62:45-53.
123. Ramirez G., Toro R., Dobeli H., et al. Protection of rat primary hippocampal cultures from A beta cytotoxicity by pro-inflammatory molecules is mediated by astrocytes. Neurobiol Dis 2005, 19:243-254.
124. Tichauer J., Saud K., von Bernhardi R. Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways. Neuroimmunomodulation 2007, 14:168-174.
125. Eftekharzadeh B., Maghsoudi N., Khodagholi F. Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stress-induced amyloid beta formation in NT2N neurons. Biochimie 2010, 92:245-253.
126. Herrera-Molina R., von Bernhardi R. Transforming growth factor-beta 1 produced by hippocampal cells modulates microglial reactivity in culture. Neurobiol Dis 2005, 19:229-236.
127. Uribe-San Martin R., Herrera-Molina R., Olavarria L., et al. Reduction of beta-amyloid-induced neurotoxicity on hippocampal cell cultures by moderate acidosis is mediated by transforming growth factor beta. Neuroscience 2009, 158:1338-1347.
128. Flores B., von Bernhardi R. Transforming growth factor β1 modulates amyloid β-induced glial activation through the Smad3-dependent induction of MAPK phosphatase-1. J Alzheimer Dis 2012, 10.3233/JAD-2012-120721.
129. Herrera-Molina R., Flores B., Orellana J.A., et al. Modulation of interferon-γ-induced glial cell activation by transforming growth factor β1: a role for STAT1 and MAPK pathways. J Neurochem 2012, 123:113-123.
130. Tichauer J., von Bernhardi R. Relevance of TGFβ Smad3 pathway modulation of scavenger receptor expression and microglial cell activation for Alzheimer disease. J Neurosci Res 2012, 90:1970-1980.
131. Ramírez G., Rey S., von Bernhardi R. Proinflammatory stimuli are needed for induction of microglial cell-mediated AbetaPP244-C and Aβ-neurotoxicity in hippocampal cultures. J Alzheimers Dis 2008, 15:45-59.
132. Herrup K. Reimagining Alzheimer's disease-an age-based hypothesis. J Neurosci 2010, 30:16755-16762.
133. Blalock E.M., Chen K.C., Stromberg A.J., et al. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation. Ageing Res Rev 2005, 4:481-512.
134. Lee M., Cho T., Jantaratnotai N., et al. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J 2010, 24:2533-2545.
135. McGeer P.L., McGeer E.G. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 2001, 22:799-809.
136. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med 2006, 12:1005-1015.
137. Rebrin I., Sohal R.S. Pro-oxidant shift in glutathione redox state during aging. Adv Drug Deliv Rev 2008, 60:1545-1552.
138. Schuitemaker A., van der Doef T.F., Boellaard R., et al. Microglial activation in healthy aging. Neurobiol Aging 2010, 33:1067-1072.
139. Liao C.K., Wang S.M., Chen Y.L., et al. Lipopolysaccharide-induced inhibition of connexin43 gap junction communication in astrocytes is mediated by downregulation of caveolin-3. Int J Biochem Cell Biol 2010, 42:762-770.
140. Orellana J.A., Hernández D.E., Ezan P., et al. Hypoxia in high glucose followed by reoxygenation in normal glucose reduces the viability of cortical astrocytes through increased permeability of connexin 43 hemichannels. Glia 2010, 58:329-343.
141. Zvalova D., Cordier J., Mesnil M., et al. p38/SAPK2 controls gap junction closure in astrocytes. Glia 2004, 46:323-333.
142. Haghikia A., Ladage K., Lafenetre P., et al. Intracellular application of TNF-alpha impairs cell to cell communication via gap junctions in glioma cells. J Neurooncol 2008, 86:143-152.
143. Bolanos J.P., Medina J.M. Induction of nitric oxide synthase inhibits gap junction permeability in cultured rat astrocytes. J Neurochem 1996, 66:2091-2099.
144. Rouach N., Calvo C.F., Glowinski J., et al. Brain macrophages inhibit gap junctional communication and downregulate connexin 43 expression in cultured astrocytes. Eur J Neurosci 2002, 15:403-407.
145. Faustmann P.M., Haase C.G., Romberg S., et al. Microglia activation influences dye coupling and Cx43 expression of the astrocytic network. Glia 2003, 42:101-108.
146. Hinkerohe D., Smikalla D., Haghikia A., et al. Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model. Glia 2005, 52:85-97.
147. Froger N., Orellana J.A., Calvo C.F., et al. Inhibition of cytokine-induced connexin43 hemichannel activity in astrocytes is neuroprotective. Mol Cell Neurosci 2010, 45:37-46.
148. Berthoud V.M., Beyer E.C. Oxidative stress, lens gap junctions, and cataracts. Antioxid Redox Signal 2009, 11:339-353.
149. Johnson L.N., Koval M. Cross-talk between pulmonary injury, oxidant stress, and gap junctional communication. Antioxid Redox Signal 2009, 11:355-367.
150. Ramachandran S., Xie L.H., John S.A., et al. A novel role for connexin hemichannel in oxidative stress and smoking-induced cell injury. PLoS One 2007, 2:e712.
151. Contreras J.E., Sánchez H.A., Eugenin E.A., et al. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci USA 2002, 99:495-500.
152. Retamal M.A., Cortés C.J., Reuss L., et al. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. Proc Natl Acad Sci USA 2006, 103:4475-4480.
153. Zhang L., Deng T., Sun Y., et al. Role for nitric oxide in permeability of hippocampal neuronal hemichannels during oxygen glucose deprivation. J Neurosci Res 2008, 86:2281-2291.
154. Malinski T. Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis 2007, 11:207-218.
155. Retamal M.A., Schalper K.A., Shoji K.F., et al. Possible involvement of different connexin43 domains in plasma membrane permeabilization induced by ischemia-reperfusion. J Membr Biol 2007, 218:49-63.
156. Retamal M.A., Schalper K.A., Shoji K.F., et al. Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential. Proc Natl Acad Sci USA 2007, 104:8322-8327.
157. Ball K.K., Harik L., Gandhi G.K., et al. Reduced gap junctional communication among astrocytes in experimental diabetes: contributions of altered connexin protein levels and oxidative-nitrosative modifications. J Neurosci Res 2011, 89:2052-2067.
158. Rouach N., Calvo C.F., Duquennoy H., et al. Hydrogen peroxide increases gap junctional communication and induces astrocyte toxicity: regulation by brain macrophages. Glia 2004, 45:28-38.